Take a look at the top five CURE stories of June 2018 in this video.
Here are the top 5 CURE stories for June 2018.
5. Cooling Cap Gets FDA Approval
The Paxman Scalp Cooling System reduces the likelihood of chemotherapy-related hair loss. In this breaking news story, we covered its FDA approval for patients with solid tumors, such as ovarian, breast, colorectal and prostate cancers.
4. What’s a Cancerversary — and Who is Ned?
Cancer terminology isn't always easy to understand. This piece by contributor Bonnie Annis aims to help you understand two phrases much better — and explains “who” Ned is.
3. First Roundup Case Goes to Court
More than 800 individuals with cancer are reportedly suing agricultural giant Monsanto, claiming its popular herbicide, Roundup, causes cancer. We cover the first case to go to trial in this web exclusive.
2. When Does Grief End?
Contributor Jane Biehl explores how the loss of health is a huge factor in grief and depression, and how a cancer diagnosis is no exception.
1. Team Player
Television journalist and former Today show co-anchor Katie Couric sits down with CURE to discuss her lifesaving contributions to the oncology community in this interview featured in our Spring issue.
In related news, did you know that CURE hosts a weekly podcast? Each week on CURE Talks Cancer, we talk with patients, survivors, caregivers, and health care professionals about the whole spectrum of cancer care. Past episodes include discussions with Patrick Dempsey and Amy Robach. Visit curetoday.com/podcasts to listen to our full library, and subscribe so you don’t miss future episodes on topics like returning to work after cancer, and the importance of support groups.
And, as always, for links to all of our top stories and more, visit curetoday.com.
Tecentriq Plus Perjeta, Chemo Does Not Improve pCR in HER2+ Breast Cancer
December 8th 2023A recent phase 3 APTneo Michelangelo trial added Tecentriq to neoadjuvant Herceptin plus Perjeta and chemotherapy which did not lead to a statistically significant improvement in pathologic complete response in patients with HER2-positive operable breast cancer.
Read More
‘The Complete Guide to Breast Reconstruction’ Author Empowers Patients With Information
October 5th 2023Now in its fifth edition, “The Complete Guide to Breast Reconstruction: Choosing the Best Options After Your Mastectomy” by two-time breast cancer survivor Kathy Steligo offers patients comprehensive, up-to-date information.
Listen